This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

MOA

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What MOA Means in Everyday Medical Language

MOA, or Mechanism of Action, is a scientific term that explains how a medicine or treatment produces its effects in the body. In cancer care, it describes what a treatment targets—such as cancer cells, specific proteins, hormones, or the immune system—and how it acts to control or eliminate cancer. For example, some drugs damage cancer cells directly, while others help the immune system recognize and attack cancer.

Why MOA Matters in Cancer Care

Cancer is not one disease but many, each with unique features. Treatments are designed to target specific weaknesses in cancer cells. Understanding a treatment’s MOA helps doctors select therapies that best fit a patient’s cancer type and biology. It also helps predict possible side effects and guides combining treatments to improve effectiveness. For patients and caregivers, knowing the MOA can make treatment plans clearer and support informed discussions with the care team.

Common Types of MOA in Cancer Treatments

Chemotherapy drugs often work by damaging the DNA of rapidly dividing cells, which includes cancer cells but can also affect healthy cells like those in hair follicles or the digestive tract. Targeted therapies block specific molecules or pathways that cancer cells need to grow. Hormone therapies reduce or block hormones that certain cancers depend on. Immunotherapies help the immune system detect and destroy cancer cells, sometimes by blocking cancer’s ability to hide from immune attacks. Other treatments may block blood vessel growth to tumors, cutting off their supply of nutrients.

What Patients Might See or Hear About MOA

When discussing treatment options, doctors may explain how a drug works by describing its MOA. For example, a monoclonal antibody like dinutuximab (Ch14.18) targets a molecule called GD2 on neuroblastoma cells and helps the immune system attack them. Understanding this can help patients know why a treatment is chosen and what to expect during therapy. MOA may also come up in treatment plans, drug information sheets, or clinical trial descriptions.

What MOA Does Not Automatically Mean

Knowing a treatment’s MOA does not guarantee it will work for every patient. Effectiveness depends on many factors, including the cancer’s genetics, the patient’s overall health, and how the cancer responds. Also, different drugs can share similar MOAs but vary in strength, side effects, and how they are given. MOA is one piece of the puzzle, not a complete prediction of treatment success.

Questions Patients Can Ask About MOA

Patients and caregivers may find it helpful to ask their care team: How does this treatment work against my cancer? What side effects are related to its MOA? Are there tests to see if this treatment is likely to help? How does this treatment fit with others I’m receiving? Understanding these points can support better communication and decision-making.

Safety and Context

This information is meant to help you understand the concept of MOA in cancer treatment. It does not replace personalized medical advice. Your healthcare team considers many factors beyond MOA when recommending treatments. Always discuss your specific situation and treatment options with your doctors.

Next Steps

If you hear about MOA during your care, use it as a starting point to learn more about your treatment. Asking your care team to explain how your medicines work and what to expect can help you feel more confident and involved in your care plan.

Sources

Public source information used for this glossary entry includes: